Organ Transplantation Market Analysis and Forecast to 2023 from Vinit's blog

Organ transplantation is one of the significant developments in modern-day medicine. Organ transplantation is a medical procedure in which the organ is removed from one body and transferred to another body to replace the organ that is missing or damaged.

One of the major aspects of organ transplantation is the approval of the patient or the patient's family. Organ harvesting without prior permission is illegal and a serious crime. Organ transplantation is typically performed with a brain-dead patient whose other organs are healthy and can be used to save another person's life.

As per Market Research Future (MRFR) analysis, the global organ transplantation market is expected to grow at 9.8% CAGR from 2017 to 2023 (forecast period). 

Market Dynamics

The key driver of organ transplant demand is the rise in the prevalence of chronic diseases and organ failure. Increased incidence of kidney disease, over-consumption of alcohol, and insalubrious diets have led to the development of the organ transplantation market. Whereas the high costs of transplantation, the small number of donors, and the rising incidence of organ failure have restricted the industry's growth.

Market Segmentation

The global market for organ transplantation has been segmented into type, product, type of transplant, treatment, and end-users. 

Based on type, the global market for organ transplantation has been segmented into organs, heart, kidney, liver, lungs, and other. 

Based on products, the global market for organ transplantation has been segmented into organ preservation solutions, transplant diagnostics, tissue products, and others. 

Based on the type of transplant, the global market for organ transplantation has been segmented into autograft, xenograft and xenotransplantation, allograft and all transplantation, and others.

Based on treatment, the global market for organ transplantation has been segmented into immunosuppressant, analgesic, and other. Immunosuppressant is further divided into calcineurin inhibitors, mTOR inhibitor, ant proliferative agents, steroids, and others. Calcineurin Inhibitors are sub-segmented into tacrolimus and cyclosporine. mTOR inhibitor is sub-segmented into sirolimus and everolimus.

Based on end-users, the global market for organ transplantation has been segmented into hospitals, transplant centers, and others. 

Key Drivers

Some of the leading participants in the global organ transplantation market are Terumo Medical Corporation (US), Transonic (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis International AG (Switzerland), OrganOX Limited (UK), Bio Med Pvt. Ltd. (US), Astellas Pharma, Inc (Japan), Transplant Biomedical (UK), TransMedic, Inc. (US), Accord Healthcare GmbH (Spain), Preservation Solutions, Inc. (US), Sanofi (France), Pfizer, Inc. (US), Veloxis Pharmaceuticals A/S (Denmark), GlaxoSmithKline Plc. (UK). 

 


Previous post     
     Next post
     Blog home

The Wall

No comments
You need to sign in to comment

Post

By Vinit
Added Jun 10

Rate

Your rate:
Total: (0 rates)

Archives